Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.39119 | 54 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.26878 | 52 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.32245 | 54 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.11805 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.25699 | 53 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.45371 | 55 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.34612 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.3739 | 55 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.30177 | 54 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.34214 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.30449 | 53 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.30481 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.3399 | 54 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.30686 | 53 |